News
A specific type of fungal species, Candida auris, is raising concern in health care facilities around the world. First discovered in Japan in 2009, Candida auris is responsible for an increasing number of serious and often fatal fungal infections. Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo Clinic Laboratories, explains why these infections are difficult to treat.
Thank you to all laboratory professionals for their efforts to provide critical answers for patients every day, and drive innovation in the field of medicine.
Top highlights include: Millions expected to lose dental care coverage, overdose deaths of elderly on the rise, and Minnesota Health Department urges caution for well owners as flood waters rise.
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides insight on the newest COVID-19 subvariant – XBB.1.16, also known as “Arcturus.”
Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, provides an update on the ongoing global avian influenza outbreak and what’s being done to prepare for a potential human-to-human outbreak.
Top highlights include: Adderall shortage is taking a toll, scientists are reconsidering the dangers of prospecting for unknown viruses, and can community paramedcine improve health outcomes in rural America?
Having an efficient and effective supply provision program is a cornerstone for laboratory outreach program success. By providing adequate specimen collection supplies in compliance with current regulations, the outreach laboratory-customer relationship is certain to succeed.
Mayo Clinic Laboratories is excited to participate in the American Academy of Neurology Annual Meeting, taking place in person in Boston on April 22–27, 2023.
Top highlights include: Government to launch $300M Azlheimer's research database, new COVID variant XBB.1.16 spotted in 18 US states, and novel treatment shows promise against rare cancer in kids.
In March 2023, Mayo Clinic Laboratories announced twenty nine new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Today's Highlights Include: US FDA seeks to allow salt substitutes in everyday foods, radioactive water leaks at Minn. nuclear plant for 2nd time, and pushback grows over mental health impacts of social media.
Mayo Clinic Laboratories is thrilled to participate in the American Academy of Neurology Annual Meeting 2023.
Today's highlights include: End of Covid emergency will usher in changes across the US health system, vaccine makers prep bird flu shot for humans ‘just in case’; rich nations lock in supplies, and a nuclear power plant leaked contaminated water in Minnesota.